Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.

Jiao S, Subudhi SK, Aparicio A, Ge Z, Guan B, Miura Y, Sharma P.

Cell. 2019 Nov 14;179(5):1177-1190.e13. doi: 10.1016/j.cell.2019.10.029.

PMID:
31730856
2.

Characterization of Antimonium crudum Activity Using Solvatochromic Dyes.

Bonamin LV, Pedro RRP, Mota HMG, Aguiar MSC, Pinto SAG, de Souza J, de Oliveira LHS, Aparicio AC, Peres GB, Suffredini I, Dutra-Correa M, Cartwright SJ.

Homeopathy. 2019 Oct 11. doi: 10.1055/s-0039-1697000. [Epub ahead of print]

PMID:
31604351
3.

Validation of the sixth version of the Addiction Severity Index (ASI-6) for patients in a clinical population of Colombia

Zapata JP, García J, Arroyave CA, Calderón JD, Gómez JM, Buitrago DJ, Aparicio A, Aguirre DC.

Biomedica. 2019 Jun 15;39(2):385-404. doi: 10.7705/biomedica.v39i3.4536. English, Spanish.

4.

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.

Corn PG, Heath EI, Zurita A, Ramesh N, Xiao L, Sei E, Li-Ning-Tapia E, Tu SM, Subudhi SK, Wang J, Wang X, Efstathiou E, Thompson TC, Troncoso P, Navin N, Logothetis CJ, Aparicio AM.

Lancet Oncol. 2019 Oct;20(10):1432-1443. doi: 10.1016/S1470-2045(19)30408-5. Epub 2019 Sep 9.

PMID:
31515154
5.

Radiotherapy for metastatic prostate cancer.

Aparicio A, Thall P, Logothetis C.

Lancet. 2019 Sep 7;394(10201):829-830. doi: 10.1016/S0140-6736(19)31783-0. No abstract available.

PMID:
31498098
6.

Progression of the functional deficit in a group of patients with bipolar disorder: a cluster analysis based on longitudinal data.

López-Villarreal A, Sánchez-Morla EM, Jiménez-López E, Martínez-Vizcaíno V, Aparicio AI, Mateo-Sotos J, Rodriguez-Jimenez R, Vieta E, Santos JL.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug 17. doi: 10.1007/s00406-019-01050-9. [Epub ahead of print]

PMID:
31422453
7.

MCCB cognitive profile in Spanish first episode schizophrenia patients.

Rodriguez-Jimenez R, Santos JL, Dompablo M, Santabárbara J, Aparicio AI, Olmos R, Jiménez-López E, Sánchez-Morla E, Lobo A, Palomo T, Kern RS, Green MF, Nuechterlein KH, García-Fernández L.

Schizophr Res. 2019 Sep;211:88-92. doi: 10.1016/j.schres.2019.07.011. Epub 2019 Jul 22.

PMID:
31345706
8.

Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma.

Laudato S, Aparicio A, Giancotti FG.

Trends Cancer. 2019 Jul;5(7):440-455. doi: 10.1016/j.trecan.2019.05.008. Epub 2019 Jun 29. Review.

PMID:
31311658
9.

Prostate Cancer: Quo Vadis?

Logothetis CJ, Aparicio A, Koinis F, Corn PG, Efstathiou E.

Eur Urol. 2019 Dec;76(6):709-711. doi: 10.1016/j.eururo.2019.06.031. Epub 2019 Jul 9.

PMID:
31300238
10.

Genetic diversity and differentiation in narrow versus widespread taxa of Helianthemum (Cistaceae) in a hotspot: The role of geographic range, habitat, and reproductive traits.

Martín-Hernanz S, Martínez-Sánchez S, Albaladejo RG, Lorite J, Arroyo J, Aparicio A.

Ecol Evol. 2019 Mar 5;9(6):3016-3029. doi: 10.1002/ece3.4481. eCollection 2019 Mar.

11.

Digital Technology for Internet Access by Patients With Early-Stage Schizophrenia in Spain: Multicenter Research Study.

Fernández-Sotos P, Fernández-Caballero A, González P, Aparicio AI, Martínez-Gras I, Torio I, Dompablo M, García-Fernández L, Santos JL, Rodriguez-Jimenez R.

J Med Internet Res. 2019 Mar 14;21(4):e11824. doi: 10.2196/11824.

12.

Beyond the United States Medical Licensing Examination Score: Assessing Competence for Entering Residency.

Radabaugh CL, Hawkins RE, Welcher CM, Mejicano GC, Aparicio A, Kirk LM, Skochelak SE.

Acad Med. 2019 Jul;94(7):983-989. doi: 10.1097/ACM.0000000000002728.

PMID:
30920448
13.

Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927.

Kahraman M, Govek SP, Nagasawa JY, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Liu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Heyman R, Rix PJ, Hager JH, Smith ND.

ACS Med Chem Lett. 2018 Dec 6;10(1):50-55. doi: 10.1021/acsmedchemlett.8b00414. eCollection 2019 Jan 10.

PMID:
30655946
14.

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.

Joseph JD, Darimont B, Zhou W, Arrazate A, Young A, Ingalla E, Walter K, Blake RA, Nonomiya J, Guan Z, Kategaya L, Govek SP, Lai AG, Kahraman M, Brigham D, Sensintaffar J, Lu N, Shao G, Qian J, Grillot K, Moon M, Prudente R, Bischoff E, Lee KJ, Bonnefous C, Douglas KL, Julien JD, Nagasawa JY, Aparicio A, Kaufman J, Haley B, Giltnane JM, Wertz IE, Lackner MR, Nannini MA, Sampath D, Schwarz L, Manning HC, Tantawy MN, Arteaga CL, Heyman RA, Rix PJ, Friedman L, Smith ND, Metcalfe C, Hager JH.

Elife. 2019 Jan 7;8. pii: e44851. doi: 10.7554/eLife.44851.

15.

Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft.

Govek SP, Bonnefous C, Julien JD, Nagasawa JY, Kahraman M, Lai AG, Douglas KL, Aparicio AM, Darimont BD, Grillot KL, Joseph JD, Kaufman JA, Lee KJ, Lu N, Moon MJ, Prudente RY, Sensintaffar J, Rix PJ, Hager JH, Smith ND.

Bioorg Med Chem Lett. 2019 Feb 1;29(3):367-372. doi: 10.1016/j.bmcl.2018.12.042. Epub 2018 Dec 19.

PMID:
30587451
16.

A biosensor-based approach reveals links between efflux pump expression and cell cycle regulation in pleiotropic drug resistance of yeast.

Li J, Kolberg K, Schlecht U, St Onge RP, Aparicio AM, Horecka J, Davis RW, Hillenmeyer ME, Harvey CJB.

J Biol Chem. 2019 Jan 25;294(4):1257-1266. doi: 10.1074/jbc.RA118.003904. Epub 2018 Dec 4.

PMID:
30514758
17.

Sources of Dietary Sodium in Food and Beverages Consumed by Spanish Schoolchildren between 7 and 11 Years Old by the Degree of Processing and the Nutritional Profile.

Cuadrado-Soto E, Peral-Suarez Á, Aparicio A, Perea JM, Ortega RM, López-Sobaler AM.

Nutrients. 2018 Dec 3;10(12). pii: E1880. doi: 10.3390/nu10121880.

18.

Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up.

Jiménez-López E, Sánchez-Morla EM, López-Villarreal A, Aparicio AI, Martínez-Vizcaíno V, Vieta E, Rodriguez-Jimenez R, Santos JL.

Eur Psychiatry. 2019 Feb;56:60-68. doi: 10.1016/j.eurpsy.2018.11.008. Epub 2018 Nov 28.

PMID:
30500572
19.

[Egg as a source of antioxidants and bioactive components against chronic processes].

Aparicio A, Salas González MªD, Cuadrado-Soto E, Ortega RM, López-Sobaler AM.

Nutr Hosp. 2018 Sep 7;35(Spec No6):36-40. doi: 10.20960/nh.2285. Review. Spanish.

20.

[Importance of breakfast in the nutritional and health improvement of the population].

López-Sobaler AMª, Cuadrado-Soto E, Peral-Suárez Á, Aparicio A, Ortega RMª.

Nutr Hosp. 2018 Sep 7;35(Spec No6):3-6. doi: 10.20960/nh.2278. Spanish.

21.

Documentation of Late-Effects Risks and Screening Recommendations for Adolescent and Young Adult Central Nervous System, Soft Tissue, or Bone Tumor Survivors Treated with Radiotherapy in British Columbia, Canada.

Howard AF, Tran J, Aparicio A, Lo A, Ullett A, McKenzie M, Srikanthan A, Goddard K.

J Adolesc Young Adult Oncol. 2019 Apr;8(2):142-148. doi: 10.1089/jayao.2018.0081. Epub 2018 Oct 9.

PMID:
30307359
22.

Development of a translational medicine protocol for an NCTN genitourinary clinical trial: Critical steps, common pitfalls and a basic guide to translational clinical research.

Meeks JJ, Goldkorn A, Aparicio AM, McConkey DJ.

Urol Oncol. 2019 May;37(5):313-317. doi: 10.1016/j.urolonc.2018.06.008. Epub 2018 Aug 13. Review.

PMID:
30115512
23.

Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast Cancer.

Nagasawa J, Govek S, Kahraman M, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Lu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Maheu K, Heyman R, Rix PJ, Hager JH, Smith ND.

J Med Chem. 2018 Sep 13;61(17):7917-7928. doi: 10.1021/acs.jmedchem.8b00921. Epub 2018 Sep 4.

PMID:
30086626
24.

Impact of number of episodes on neurocognitive trajectory in bipolar disorder patients: a 5-year follow-up study.

Sánchez-Morla EM, López-Villarreal A, Jiménez-López E, Aparicio AI, Martínez-Vizcaíno V, Roberto RJ, Vieta E, Santos JL.

Psychol Med. 2019 Jun;49(8):1299-1307. doi: 10.1017/S0033291718001885. Epub 2018 Jul 25.

PMID:
30043716
25.

Developmental trajectories of children with Down syndrome by socio-economic status: the case of Latin America.

Arango PS, Aparicio A, Tenorio M.

J Intellect Disabil Res. 2018 Sep;62(9):759-774. doi: 10.1111/jir.12516. Epub 2018 Jul 8.

PMID:
29984471
26.

EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

Soundararajan R, Paranjape AN, Maity S, Aparicio A, Mani SA.

Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):229-238. doi: 10.1016/j.bbcan.2018.06.006. Epub 2018 Jul 5. Review.

PMID:
29981816
27.

Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.

Goswami S, Apostolou I, Zhang J, Skepner J, Anandhan S, Zhang X, Xiong L, Trojer P, Aparicio A, Subudhi SK, Allison JP, Zhao H, Sharma P.

J Clin Invest. 2018 Aug 31;128(9):3813-3818. doi: 10.1172/JCI99760. Epub 2018 Jul 30.

28.

Screening for selective anticancer activity of plants from Grazalema Natural Park, Spain.

Calderón-Montaño JM, Martínez-Sánchez SM, Burgos-Morón E, Guillén-Mancina E, Jiménez-Alonso JJ, García F, Aparicio A, López-Lázaro M.

Nat Prod Res. 2019 Dec;33(23):3454-3458. doi: 10.1080/14786419.2018.1480620. Epub 2018 May 29.

PMID:
29842791
29.

Adequacy of usual macronutrient intake and macronutrient distribution in children and adolescents in Spain: A National Dietary Survey on the Child and Adolescent Population, ENALIA 2013-2014.

López-Sobaler AM, Aparicio A, Rubio J, Marcos V, Sanchidrián R, Santos S, Pérez-Farinós N, Dal-Re MÁ, Villar-Villalba C, Yusta-Boyo MJ, Robledo T, Castrodeza-Sanz JJ, Ortega RM.

Eur J Nutr. 2019 Mar;58(2):705-719. doi: 10.1007/s00394-018-1676-3. Epub 2018 May 22.

30.

ER stress in prostate cancer: A therapeutically exploitable vulnerability?

Logothetis C, Aparicio A, Thompson TC.

Sci Transl Med. 2018 May 2;10(439). pii: eaat3975. doi: 10.1126/scitranslmed.aat3975. Review.

PMID:
29720450
31.

Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes.

Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF.

Eur Urol. 2018 Aug;74(2):140-143. doi: 10.1016/j.eururo.2018.03.031. Epub 2018 Apr 12.

PMID:
29656854
32.

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.

Soundararajan R, Aparicio AM, Logothetis CJ, Mani SA, Maity SN.

Front Oncol. 2018 Mar 15;8:69. doi: 10.3389/fonc.2018.00069. eCollection 2018. Review.

33.

Differences in meal patterns and timing with regard to central obesity in the ANIBES ('Anthropometric data, macronutrients and micronutrients intake, practice of physical activity, socioeconomic data and lifestyles in Spain') Study - CORRIGENDUM.

Aparicio A, Rodríguez-Rodríguez E, Aranceta-Bartrina J, Gil Á, González-Gross M, Serra-Majem L, Varela-Moreiras G, Ortega RM.

Public Health Nutr. 2018 Jun;21(8):1588. doi: 10.1017/S1368980017003068. Epub 2018 Mar 6. No abstract available.

PMID:
29506590
34.

Reply to Comment on "Alternative acute oral toxicity assessment under REACH based on sub-acute toxicity values".

Gissi A, Louekari K, Hoffstadt L, Bornatowicz N, Aparicio AM.

ALTEX. 2018;35(1):121-122. doi: 10.14573/altex.1712011. No abstract available.

35.

Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.

Jiménez-López E, Sánchez-Morla EM, Aparicio AI, López-Villarreal A, Martínez-Vizcaíno V, Rodriguez-Jimenez R, Vieta E, Santos JL.

J Affect Disord. 2018 Mar 15;229:177-185. doi: 10.1016/j.jad.2017.12.094. Epub 2018 Jan 2.

PMID:
29316520
36.

Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.

Zhang W, Liu B, Wu W, Li L, Broom BM, Basourakos SP, Korentzelos D, Luan Y, Wang J, Yang G, Park S, Azad AK, Cao X, Kim J, Corn PG, Logothetis CJ, Aparicio AM, Chinnaiyan AM, Navone N, Troncoso P, Thompson TC.

Clin Cancer Res. 2018 Feb 1;24(3):696-707. doi: 10.1158/1078-0432.CCR-17-1872. Epub 2017 Nov 14.

37.

Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy.

Bilen MA, Hess KR, Subudhi SK, Aparicio A, Kim J, Zurita-Saavedra AJ, Araujo JC, Corn PG, Stover J, Lin SH, Logothetis CJ, Tu SM.

Cancer Chemother Pharmacol. 2017 Sep;80(3):583-589. doi: 10.1007/s00280-017-3391-9. Epub 2017 Jul 20.

PMID:
28730293
38.

Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.

Jiménez-López E, Aparicio AI, Sánchez-Morla EM, Rodriguez-Jimenez R, Vieta E, Santos JL.

J Affect Disord. 2017 Nov;222:169-176. doi: 10.1016/j.jad.2017.07.014. Epub 2017 Jul 8.

PMID:
28709024
39.

Quantitative analysis of protein interaction network dynamics in yeast.

Celaj A, Schlecht U, Smith JD, Xu W, Suresh S, Miranda M, Aparicio AM, Proctor M, Davis RW, Roth FP, St Onge RP.

Mol Syst Biol. 2017 Jul 13;13(7):934. doi: 10.15252/msb.20177532.

40.

Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.

Ganeshan D, Aparicio AM, Morani A, Kundra V.

AJR Am J Roentgenol. 2017 Aug;209(2):327-332. doi: 10.2214/AJR.16.17214. Epub 2017 Jun 7.

PMID:
28590819
41.

Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.

Li L, Karanika S, Yang G, Wang J, Park S, Broom BM, Manyam GC, Wu W, Luo Y, Basourakos S, Song JH, Gallick GE, Karantanos T, Korentzelos D, Azad AK, Kim J, Corn PG, Aparicio AM, Logothetis CJ, Troncoso P, Heffernan T, Toniatti C, Lee HS, Lee JS, Zuo X, Chang W, Yin J, Thompson TC.

Sci Signal. 2017 May 23;10(480). pii: eaam7479. doi: 10.1126/scisignal.aam7479.

42.

Differences in meal patterns and timing with regard to central obesity in the ANIBES ('Anthropometric data, macronutrients and micronutrients intake, practice of physical activity, socioeconomic data and lifestyles in Spain') Study.

Aparicio A, Rodríguez-Rodríguez EE, Aranceta-Bartrina J, Gil Á, González-Gross M, Serra-Majem L, Varela-Moreiras G, Ortega RM.

Public Health Nutr. 2017 Sep;20(13):2364-2373. doi: 10.1017/S1368980017000635. Epub 2017 Apr 17. Erratum in: Public Health Nutr. 2018 Jun;21(8):1588.

43.

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.

Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam GC, Broom B, Aparicio AM, Gallick GE, Troncoso P, Corn PG, Navone N, Zhang W, Li S, Thompson TC.

Cell Rep. 2017 Feb 21;18(8):1970-1981. doi: 10.1016/j.celrep.2017.01.072.

44.

Adequacy of Usual Vitamin and Mineral Intake in Spanish Children and Adolescents: ENALIA Study.

López-Sobaler AM, Aparicio A, González-Rodríguez LG, Cuadrado-Soto E, Rubio J, Marcos V, Sanchidrián R, Santos S, Pérez-Farinós N, Dal Re MÁ, Villar C, Robledo T, Castrodeza JJ, Ortega RM.

Nutrients. 2017 Feb 13;9(2). pii: E131. doi: 10.3390/nu9020131.

45.

Role of radical prostatectomy in metastatic prostate cancer: A review.

Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF.

Urol Oncol. 2017 Apr;35(4):125-134. doi: 10.1016/j.urolonc.2017.01.001. Epub 2017 Feb 9. Review.

PMID:
28190749
46.

Emotion processing and psychosocial functioning in euthymic bipolar disorder.

Aparicio A, Santos JL, Jiménez-López E, Bagney A, Rodríguez-Jiménez R, Sánchez-Morla EM.

Acta Psychiatr Scand. 2017 Apr;135(4):339-350. doi: 10.1111/acps.12706. Epub 2017 Feb 11.

PMID:
28188631
47.

Low Adherence to Dietary Guidelines in Spain, Especially in the Overweight/Obese Population: The ANIBES Study.

Rodríguez-Rodríguez E, Aparicio A, Aranceta-Bartrina J, Gil Á, González-Gross M, Serra-Majem L, Varela-Moreiras G, Ortega RM.

J Am Coll Nutr. 2017 May-Jun;36(4):240-247. doi: 10.1080/07315724.2016.1248246. Epub 2017 Jan 12.

PMID:
28080834
48.

The relationship between hours of sleep, screen time and frequency of food and drink consumption in Spain in the 2011 and 2013 ALADINO: a cross-sectional study.

Pérez-Farinós N, Villar-Villalba C, López Sobaler AM, Dal Re Saavedra MÁ, Aparicio A, Santos Sanz S, Robledo de Dios T, Castrodeza-Sanz JJ, Ortega Anta RM.

BMC Public Health. 2017 Jan 6;17(1):33. doi: 10.1186/s12889-016-3962-4.

49.

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.

Basourakos SP, Li L, Aparicio AM, Corn PG, Kim J, Thompson TC.

Curr Med Chem. 2017;24(15):1586-1606. doi: 10.2174/0929867323666161214114948. Review.

50.

Reply to J.B. Aragon-Ching and D. Dalela et al.

Aparicio A, Logothetis CJ.

J Clin Oncol. 2017 Mar 10;35(8):917-918. doi: 10.1200/JCO.2016.70.9238. Epub 2016 Dec 12. No abstract available.

PMID:
27937088

Supplemental Content

Loading ...
Support Center